SYSTEMATIC LITERATURE REVIEW OF NMAS AND POPULATION ADJUSTED INDIRECT COMPARISONS OF BIOLOGICAL TREATMENTS IN MODERATE-TO-SEVERE PSORIASIS

被引：0
|
作者：
Llinares, Garcia, I [1 ]
Hernando, T. [1 ]
Kohout, M. [2 ]
机构：
[1] Janssen, Madrid, Spain
[2] Janssen, Neuss, Germany
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PBI9
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [41] French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults
    Amatore, F.
    Villani, A-P
    Tauber, M.
    Guillot, B.
    Viguier, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (6-7): : 429 - 439
  • [42] Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population
    Papp, Kim
    Valenzuela, Fernando
    Poulin, Yves
    Bernstein, Geula
    Wasel, Norman
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2010, 14 (04) : 167 - 174
  • [43] Treatments for Moderate-to-Severe Acne Vulgaris: A Systematic Review and Network Meta-Analysis
    Harper, Julie C.
    Baldwin, Hilary
    Choudhury, Saswata Paul
    Rai, Deepti
    Ghosh, Bikramaditya
    Aman, Md Sohail
    Choudhury, Abhra R.
    Dutta, Sekhar Kumar
    Dey, Debalina
    Bhattacharyya, Subrata
    Lin, Tina
    Joseph, George
    Dashputre, Ankur A.
    Tan, Jerry K. L.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (04) : 216 - 226
  • [44] Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab
    Warren, R. B.
    Brnabic, A.
    Saure, D.
    Langley, R. G.
    See, K.
    Wu, J. J.
    Schacht, A.
    Mallbris, L.
    Nast, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (05) : 1064 - 1071
  • [45] Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
    Hampton, Philip
    Borg, Emma
    Hansen, Jes Birger
    Augustin, Matthias
    PSORIASIS-TARGETS AND THERAPY, 2021, 11 : 123 - 131
  • [46] Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis
    Wong, Ian T. Y.
    Shojania, Kam
    Dutz, Jan
    Tsao, Nicole W.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (02) : 153 - 166
  • [47] Histone modifications associated with biological drug response in moderate-to-severe psoriasis
    Ovejero-Benito, Maria C.
    Reolid, Alejandra
    Sanchez-Jimenez, Patricia
    Saiz-Rodriguez, Miriam
    Munoz-Aceituno, Ester
    Llamas-Velasco, Mar
    Martin-Vilchez, Samuel
    Cabaleiro, Teresa
    Roman, Manuel
    Ochoa, Dolores
    Dauden, Esteban
    Abad-Santos, Francisco
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (12) : 1361 - 1371
  • [48] Insurance coverage of biologics for moderate-to-severe psoriasis: A database review
    Abdelnabi, Mai
    Patel, Aakash
    Rengifo-Pardo, Monica
    Ehrlich, Alison
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB256 - AB256
  • [49] Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
    Barker, Jonathan
    Baker, Hannah
    Nadeem, Ayeda
    Gu, Dong-Ha
    Girolomoni, Giampiero
    CLINICAL DRUG INVESTIGATION, 2021, 41 (11) : 1011 - 1020
  • [50] A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis
    Roostaeyan, Omid
    Kivelevitch, Dario
    Menter, Alan
    IMMUNOTHERAPY, 2017, 9 (12) : 963 - 978
12345